Texas AG Investigates BCBS Over Medical Care Delays

Translate to Spanish or other 102 languages!

Attorney General Ken Paxton launched an investigation into Blue Cross Blue Shield of Texas (“BCBSTX”), its parent company, Health Care Service Corporation (“HCSC”), and their related business entities. This investigation is based on BCBSTX’s procedures for denying and delaying urgent and medically necessary care and its potentially burdensome prior authorization requirements. Image for illustration purposes
Attorney General Ken Paxton launched an investigation into Blue Cross Blue Shield of Texas (“BCBSTX”), its parent company, Health Care Service Corporation (“HCSC”), and their related business entities. This investigation is based on BCBSTX’s procedures for denying and delaying urgent and medically necessary care and its potentially burdensome prior authorization requirements. Image for illustration purposes
- Advertisement -

AUSTIN – Attorney General Ken Paxton launched an investigation into Blue Cross Blue Shield of Texas (“BCBSTX”), its parent company, Health Care Service Corporation (“HCSC”), and their related business entities. This investigation is based on BCBSTX’s procedures for denying and delaying urgent and medically necessary care and its potentially burdensome prior authorization requirements.

Reports received by the OAG indicate that BCBSTX may have denied or delayed coverage for procedures deemed medically necessary or urgent. One case reported to the OAG involved a newborn baby in need of urgent medical treatment. Although the procedure was allegedly covered under the applicable health plan, administrative denials and potentially improper utilization review procedures delayed approval of a transfer to a facility capable of providing the care the newborn needed.

In many cases, BCBSTX allegedly delayed granting approval for medically urgent treatment. These delays may have postponed medically necessary treatment and potentially caused consumer harm. Such delays can worsen a patient’s condition, increase the risk of complications, allow disease progression, cause disability or death, and increase administrative costs.

- Advertisement -

“Blue Cross Blue Shield has a responsibility to put patients before profits and ensure that Texans receive the care they need,” said Attorney General Paxton. “When a newborn baby or any other Texan urgently needs medical treatment, an insurance company’s priority should be helping provide that care to the best of its ability—not searching for ways to delay or deny it. I will wage a relentless legal battle against any insurance company that fails to protect health and safety of Texans.”

The investigation will focus on representations made by BCBSTX regarding its approval and denial of medically necessary claims. Attorney General Paxton will determine whether claims are denied without adequate review or whether the company engages in any other unlawful practices. As part of the investigation, Attorney General Paxton has issued a Civil Investigative Demand (“CID”) to obtain information and determine whether BCBSTX, HCSC, or related entities violated Texas law, including the Texas Deceptive Trade Practices Act (“DTPA”).

As part of fair and balanced journalism, corporations named in Attorney General Ken Paxton’s investigation, includingBlue Cross Blue Shield of Texas (“BCBSTX”), and Health Care Service Corporation (“HCSC”) should be afforded the opportunity to respond to the allegations and provide their perspective. While the Attorney General’s office has announced a sweeping investigation into Blue Cross Blue Shield of Texas (“BCBSTX”), and Health Care Service Corporation (“HCSC”) and issued Civil Investigative Demands to, Blue Cross Blue Shield of Texas (“BCBSTX”), and Health Care Service Corporation (“HCSC”), the investigation remains ongoing, and no findings of wrongdoing have been made. Fair reporting requires that all parties have an opportunity to address the claims, explain their practices, and comment on the issues raised by the investigation. Send perspective to: info@tbbmega.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS and Prominence Health Empower Seniors This World Heart Day

World Heart Day serves as a powerful reminder that cardiovascular disease remains one of the greatest threats to the health and well-being of older adults.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.

DHR Health Enhances Ear, Nose, and Throat Care with Addition of Dr. Tess Hill

As part of its ongoing commitment to expanding access to outstanding healthcare throughout the Rio Grande Valley, DHR Health is pleased to welcome Dr. Tess Hill to its growing team of physicians. Dr. Hill joins DHR Health as an otolaryngologist (ear, nose and throat physician) and looks forward to providing compassionate, patient-centered care.
- Advertisement -